118
Participants
Start Date
October 9, 2018
Primary Completion Date
May 19, 2021
Study Completion Date
May 19, 2021
Sarilumab SAR153191 (REGN88)
Pharmaceutical form:solution for injection Route of administration: subcutaneous
Sarilumab-matching placebo
Pharmaceutical form:solution for injection Route of administration: subcutaneous
Prednisone
Pharmaceutical form:over-encapsulated tablets Route of administration: oral administration
Prednisone-matching placebo
Pharmaceutical form:over-encapsulated tablets Route of administration: oral administration
Prednisone
Pharmaceutical form:tablets Route of administration: oral administration
Investigational Site Number 0360001, Kogarah
Investigational Site Number 0560001, Leuven
Investigational Site Number 7560001, Bern
Investigational Site Number 5280008, Rotterdam
Investigational Site Number 0360003, Camberwell
Investigational Site Number 3480001, Debrecen
Investigational Site Number 0360002, Maroochydore
Investigational Site Number 0360004, Woodville South
Investigational Site Number 0560003, Ghent
Investigational Site Number 7560002, Sankt Gallen
Investigational Site Number 2760009, Berlin
Investigational Site Number 8400022, New York
Investigational Site Number 2760001, Berlin
Investigational Site Number 2330001, Tallinn
Investigational Site Number 2500011, Caen
Investigational Site Number 7240004, A Coruña / Santiago de Compostela
Investigational Site Number 7240008, Granada
Investigational Site Number 3800005, Rozzano
Investigational Site Number 3800003, Milan
Investigational Site Number 3800001, Milan
Investigational Site Number 7240002, Madrid
Investigational Site Number 7240001, Getafe
Investigational Site Number 2500005, Brest
Investigational Site Number 2500014, Toulouse
Investigational Site Number 3760001, Haifa
Investigational Site Number 8400002, Boca Raton
Investigational Site Number 2500003, Montpellier
Investigational Site Number 3760004, Haifa
Investigational Site Number 3800008, Verona
Investigational Site Number 7240006, Santander
Investigational Site Number 3800002, Reggio Emilia
Investigational Site Number 3760003, Kfar Saba
Investigational Site Number 7240007, Valencia
Investigational Site Number 3760002, Petah Tikva
Investigational Site Number 8400014, Iowa City
Investigational Site Number 3760005, Tel Litwinsky
Investigational Site Number 3800004, Pisa
Investigational Site Number 2500010, Lille
Investigational Site Number 2500016, Pierre-Bénite
Investigational Site Number 2760007, Tübingen
Investigational Site Number 2760003, Kirchheim unter Teck
Investigational Site Number 2500004, Paris
Investigational Site Number 8400011, Dallas
Investigational Site Number 8400025, Lufkin
Investigational Site Number 2500002, Montivilliers
Investigational Site Number 8400005, Denver
Investigational Site Number 2760004, München
Investigational Site Number 8400003, Upland
Investigational Site Number 2760008, Bad Abbach
Investigational Site Number 2500015, Le Kremlin-Bicêtre
Investigational Site Number 8400015, Spokane
Investigational Site Number 6430002, Moscow
Investigational Site Number 6430001, Moscow
Investigational Site Number 6430003, Moscow
Investigational Site Number 6430004, Moscow
Investigational Site Number 6430008, Saint Petersburg
Investigational Site Number 8400009, Stamford
Investigational Site Number 8400006, Boston
Investigational Site Number 0320001, Buenos Aires
Investigational Site Number 0320005, Buenos Aires
Investigational Site Number 0320002, Caba
Investigational Site Number 0320003, San Miguel de Tucumán
Investigational Site Number 1240007, Hamilton
Investigational Site Number 1240010, Montreal
Investigational Site Number 1240001, Rimouski
Investigational Site Number 1240005, Sherbrooke
Investigational Site Number 1240003, Trois-Rivières
Investigational Site Number 2760002, Dresden
Investigational Site Number 3920002, Fuchu-Shi
Investigational Site Number 3920003, Kamakura-Shi
Investigational Site Number 3920005, Kawachinagano-Shi
Investigational Site Number 3920001, Takasaki-Shi
Investigational Site Number 5280003, Alkmaar
Investigational Site Number 5280002, Almelo
Investigational Site Number 5280005, Leeuwarden
Investigational Site Number 5280004, Nijmegen
Investigational Site Number 5280007, The Hague
Investigational Site Number 7240005, Badalona
Investigational Site Number 8260004, Gateshead
Investigational Site Number 8260003, Leeds
Investigational Site Number 8260009, Manchester
Investigational Site Number 8260007, Newport
Investigational Site Number 8260002, Plymouth
Investigational Site Number 8260001, Southend
Lead Sponsor
Regeneron Pharmaceuticals
INDUSTRY
Sanofi
INDUSTRY